Markets

Celsius rocked by earnings miss as Pepsi shift backfires

Celsius rocked by earnings miss as Pepsi shift backfires

By Timothy Inklebarger

The energy drink maker cited SKU rationalization and a pause in innovation during its Alani Nu and Rockstar integration for the shortfall, countering investor anxiety with a $300 million stock buyback plan

Why Nestlé Waters chose joint venture over full exit

Why Nestlé Waters chose joint venture over full exit

By Donna Eastlake

Nestlé’s decision to sell 50% of its Waters business to Platinum Equity ends months of speculation. But why opt for a joint venture and what does it mean for the future of Peranel?

Science, trust and the next era of food innovation

Letter from the editor

Science, trust and the next era of food innovation

By Elizabeth Crawford

From combating food misinformation to redefining healthy eating and scaling AI-enabled innovation, IFT FIRST 2026 underscored how evidence-based science is reshaping the future of food

The GLP-1 effect reaches ANZ

The GLP-1 effect reaches ANZ

By Gill Hyslop

New research suggests Australia and New Zealand are following the same GLP-1-driven consumer shifts seen elsewhere, offering an early indication of where the wider APAC food market could head next

How Mondelēz achieved its mid-year wins

How Mondelēz achieved its mid-year wins

By Augustus Bambridge-Sutton

The snacking multinational has seen a strong second quarter, returning to volume growth and succeeding in emerging markets

Can dairy retain its bioactive benefits without sacrificing food safety?

IFT FIRST

Can dairy retain its bioactive benefits without sacrificing food safety?

By Elizabeth Crawford

By preserving naturally occurring milk exosomes that conventional processing often destroys, biotech startup Exosomm says it can help manufacturers deliver clinically relevant bioactive benefits without compromising food safety, shelf life or scalability